HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Walking exercise response to bronchodilation in mild COPD: a randomized trial.

AbstractRATIONALE:
Patients with mild chronic obstructive pulmonary disease (COPD) present abnormal ventilatory mechanics during exercise and may require bronchodilator therapy. However, bronchodilation does not enhance cycling exercise tolerance in these patients whereas walking may be more sensitive to the effects of bronchodilation.
OBJECTIVES:
To characterize the impact of bronchodilation on i) exercise tolerance ii) cardiopulmonary response and iii) dynamic hyperinflation following an endurance shuttle walking test in patients with mild COPD.
METHODS:
In a randomized double-blind cross-over trial, 37 patients with GOLD stage I COPD (FEV(1), 96 ± 2% predicted, mean ± SEM) completed an endurance shuttle walking test up to exhaustion 90 ± 15 min following nebulization of a placebo [NaCl] or of ipratropium bromide/salbutamol sulfate (500 μg/2.5 mg) combination.
RESULTS:
FEV(1) significantly increased following bronchodilation compared with placebo (0.17 ± 0.02 vs. -0.02 ± 0.01 L, p < 0.0001, mean ± SEM). The difference in walking endurance time between bronchodilation and placebo was not statistically significant (Δ15 ± 12 s, p = 0.21), with the upper and lower boundaries of the 95% confidence interval [-9-40 s, 95% CI] within the proposed minimally important difference for this variable (65 s). The ratio of breathing frequency to tidal volume tended to be decreased with bronchodilation during exercise (p = 0.07), indicating a deeper and slower breathing pattern with bronchodilation. Bronchodilation had a significant effect on dynamic hyperinflation at isotime and at peak exercise.
CONCLUSION:
Bronchodilation did not improve walking endurance in patients with mild COPD despite small physiological benefits of uncertain clinical relevance.
AuthorsPhilippe Gagnon, Didier Saey, Steeve Provencher, Julie Milot, Jean Bourbeau, Wan C Tan, Simon Martel, François Maltais
JournalRespiratory medicine (Respir Med) Vol. 106 Issue 12 Pg. 1695-705 (Dec 2012) ISSN: 1532-3064 [Electronic] England
PMID22999808 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Bronchodilator Agents
  • Ipratropium
  • Albuterol
Topics
  • Administration, Inhalation
  • Aged
  • Albuterol (administration & dosage)
  • Analysis of Variance
  • Bronchodilator Agents (administration & dosage)
  • Cross-Over Studies
  • Double-Blind Method
  • Drug Therapy, Combination
  • Exercise Test (methods)
  • Exercise Tolerance (drug effects)
  • Female
  • Humans
  • Ipratropium (administration & dosage)
  • Male
  • Oxygen Consumption (physiology)
  • Pulmonary Disease, Chronic Obstructive (drug therapy, physiopathology)
  • Quadriceps Muscle (physiology)
  • Respiratory Function Tests
  • Walking (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: